The Evidence Speaks (February 2021)
To mark Heart Month, this edition includes clinical outcomes after TAVR, scene-access delay and patient outcomes after cardiac arrest, and chest pain after an arterial tear in the heart
Read MoreJanuary 2, 2020
To mark Heart Month, this edition includes clinical outcomes after TAVR, scene-access delay and patient outcomes after cardiac arrest, and chest pain after an arterial tear in the heart
Read More
As Program Head of Health Services and Outcomes at CHÉOS, Dr. Jason Sutherland studies approaches to allocating funding as a way to improve value from health care
Read More
CHÉOS Scientists and their work on cardiovascular disease, wait-times for hip fracture repair, and colorectal surgery could be found in the media this August
Read More
Dr. Jason Sutherland was recently appointed to the MSFHR Research Leaders Forum, a group that advises MSFHR leadership on the challenges and opportunities affecting health research.
Read More
In August, four CHÉOS Scientists were officially appointed to faculty positions at the University of British Columbia School of Population and Public Health.
Read More
CHÉOS researchers were interviewed about moral distress, patient engagement, health economics, and more in March.
Read More
Dr. Sutherland will be presenting as part of our Work in Progress Seminar Series on February 15
Read More
The third installment in our new series, "The Evidence Speaks," highlighting the latest in CHÉOS research.
Read More
The second post in our new series, "The Evidence Speaks," highlighting the latest in CHÉOS research.
Read More